
This article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.

This article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.

Outlining the techniques for anonymization of clinical study reports and the identification and redaction of commercially confidential information to comply with EMA's Policy 0070 on trial data disclosure and transparency.

Metabolomics can make a positive impact from early drug discovery through clinical development and beyond.

Updated employee announcements, business news, awards, and recognition in the industry today.

The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.








Investigators aim to increase the efficiency and consistency of FDA’s Bioresearch Monitoring program.








In this article, we will suggest an introspective method that can help clarify situational analysis and resolution.



The ruling by the Pennsylvania Supreme Court requiring informed consent to be obtained by a medical doctor could set a precedent for future nationwide cases involving clinical research.


Expert outlines approaches to preventing fraud in clinical research-a more prevalent problem that many believe.

Collaboration focuses on the use of a digital toolset in medication management and patient engagement during studies.

Dealmaking spurt and key upcoming regulatory guidances point the trajectory ahead in clinical research space.

Outlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.